Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy
Life · 16.05.2023 · 13 (5) · 1194
DOI: 10.3390/life13051194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 16.05.2023. Verfasst von Peter Kiraly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency.
Abstract (Originalsprache)
Our study evaluated visual function changes after subthreshold micropulse laser (SML) treatment in persistent central serous chorioretinopathy (CSC) and SML safety profile. We conducted a prospective study including 31 fovea-involving CSC patients. The natural course was observed for the first 3 months, SML was performed at 3 months, and SML effectiveness was observed at 6 months. At all three clinical visits, optical coherence tomography (OCT), best corrected visual acuity (BCVA), contrast sensitivity (CS) in five spatial frequencies (1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree (cpd)), microperimetry (MP), and multifocal electroretinography (mfERG) were performed. The SML safety profile was evaluated with functional and morphological parameters. In the cohort of all CSC patients treated with SML, the statistically significant average improvement was observed in BCVA (p = 0.007), CS-1.5 (p = 0.020), CS-3.0 (p = 0.050), CS-12.0 (p < 0.001), CS-18.0 (p = 0.002), CS (CS-A) (p < 0.001), MP in the central ring (MP-C) (p = 0.020), peripheral ring (MP-P) (p = 0.042), and average retinal sensitivity (MP-A) (p = 0.010). After the SML treatment, mean changes in mfERG amplitudes and implicit times in our cohort were not statistically significant. No morphological or functional adverse effects of SML treatment were observed. SML treatment in persistent CSC episodes leads to significant functional improvement and has an excellent safety profile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
- Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Jožef Stefan Institute, 1000 Ljubljana, Slovenia.
ORCID-Profile: Jaka Smrekar, Polona Jaki Mekjavić
Förderung
- Slovenian Research Agency
Zitieren
APA
Kiraly, P., Habjan, M. Š., Smrekar, J., & Mekjavić, P. J. (2023). Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy. Life, 13(5), 1194. https://doi.org/10.3390/life13051194
Vancouver
Kiraly P, Habjan MŠ, Smrekar J, Mekjavić PJ. Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy. Life. 2023;13(5):1194. doi:10.3390/life13051194
BibTeX
@article{Kiraly2023,
author = {Kiraly, Peter and Habjan, Maja Šuštar and Smrekar, Jaka and Mekjavić, Polona Jaki},
title = {Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy},
journal = {Life},
year = {2023},
volume = {13},
number = {5},
pages = {1194},
doi = {10.3390/life13051194}
}
EUVIMED